People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $15.1M | $84.9M | 2011 |
John C. Deighan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John C. Deighan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Douglas L. Braunstein | 1 | 2 |
| Scott L. Tarriff | 1 | 2 |
| Scott Tarriff | 1 | 2 |
| David E Riggs | 1 | 2 |
| Michael E. Graves | 1 | 1 |
| Steven E. Ratoff | 1 | 1 |
| Robert L. Glenning | 1 | 1 |
| Gregg C. Stetsko | 1 | 1 |
| Adrian E. Hepner | 1 | 1 |
| Sander E. Flaum | 1 | 1 |
| Steven L. Krill | 1 | 1 |
| David E. Pernock | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.